乳腺癌194例临床分析

目的分析194例乳腺癌综合治疗的疗效，探讨乳腺癌治疗后影响其生存、复发、转移及预后的因素。方法对1998年6月至2008年6月在本院治疗满5年全部乳腺癌患者进行回顾性随访，将临床资料结果进行总结分析。结果本组乳腺癌5年生存率为53．09％，生存率较低与延误诊治时机、肿块分期、病理类型、腋淋巴结转移、胸肌转移、激素受体以及综合治疗情况等诸多因素有关。结论乳腺癌5年生存率虽然仅为53．09％，但如果能早期发现，早期诊断，早期进行以手术、化疗及内分泌治疗为主的综合治疗，乳腺癌生存率还可提高。

Clinical analysis of 194 cases breast cancer

Objective To analyze the general treatment efficacy of 194 cases breast cancer and explore the impacts for their survival, recurrence, metastasis and prognosis after treatment. Methods All patients with breast cancer who were at our hospital for 5 years treatment （from June 1998 to June 2008 ） were retrospectively followed up and the results of clinical data will be analyzed. Results This group of breast cancer＇ s 5-year survival rate was 53.09 percent; lower survival rate was related with delay in diagnosis and treatment, mass stage, pathological type, axillary lymph node metastasis, thorax muscle transfer, hormone receptor, comprehensive treatment and many other factors. Conclusion Breast cancer＇ s 5-year survival rate was only 53.09 percent, but if early to detect, early to diagnose and early to use surgery, chemotherapy and endocrine therapy-based combination therapy, the survival rate can be better improved.